Dr. Paul Burton and Dr. C. Michael Gibson Discuss: Effect of Evolocumab in Patients at High Cardiovascular Risk without Prior Myocardial Infarction or Stroke: Primary Results of the VESALIUS-CV trial November 8, 2025 2025 | AHA | Cardiology | Slides | Trial | Video Tags: 2025, AHA, Cardiology, slides, video AHA LBCT Slides 7Nov2025 Final for EMODownload Disclosures: TBD Article Navigation Dr. Pam Taub and Dr. C. Michael Gibson discuss: Effects of Lifestyle and Medical Therapy on Changes in Coronary Atherosclerosis: Tracking Plaque for Personalized Medicine Dr. Jeffrey I Weitz and Dr. C. Michael Gibson Discuss: ROXI~ Two Mechanistically Distinct Factor XI Antibodies, REGN9933 and REGN7508, for the Prevention of Venous Thromboembolism After Knee Arthroplasty: the ROXI-VTE-I and ROXI-VTE-II trials
